Planta Med 1994; 60(3): 244-247
DOI: 10.1055/s-2006-959468
Paper

© Georg Thieme Verlag Stuttgart · New York

Hypoglycemic and Antihyperglycemic Effects of Zizyphus spina-christi in Rats

K.-W. Glombitza1 , G. H. Mahran2 , Y. W. Mirhom2 , K. G. Michel2 , T. K. Motawi3
  • 1Institute of Pharmaceutical Biology, Bonn University, Nußallee 6, D-53115 Bonn, Federal Republic of Germany
  • 2Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt
  • 3Department of Biochemistry, Faculty of Pharmacy, Kasr El-Eini Street, Cairo University, Cairo, Egypt
Weitere Informationen

Publikationsverlauf

1993

1993

Publikationsdatum:
04. Januar 2007 (online)

Abstract

Zizyphus is one of the plants commonly used in Egyptian folk medicine for the treatment of different diseases. The present study aims to investigate the effect of the butanol extract of Zizyphus spina-christi leaves as well as christinin-A, its principle saponin glycoside, in normal and streptozotocin-diabetic rats. In normal rats, treatment in both cases for one and four weeks produced insignificant changes in all studied parameters. However, in diabetic rats, both treatments significantly reduced serum glucose level, liver phosphorylase and glucose-6-phosphatase (G-6-pase) activities, and significantly increased serum pyruvate level and liver glycogen content after 4 weeks treatment. There was also marked improvement in glucose utilization in diabetic rats in both cases. Serum insulin and pancreatic cAMP levels showed significant increases in diabetic rats treated for a period of 4 weeks with the butanol extract.